Physician profile
Daniel Rozen
NPI 1821446352
$2,059.06
in general payments reported to CMS, 2019-2025
14 companies · $665 in 2025
The $665 reported for 2025 was more than what 85% of Orthodontics and Dentofacial Orthopedics providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $207 · 2020: $90.10 · 2021: $276 · 2022: $381 · 2023: $245 · 2024: $195 · 2025: $665.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,010 · Education: $95.07.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,009.62 |
| Education | $95.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $1,107.95 | 2019-2025 | Invisalign, Invisalign Touch Up, Itero Element 5d Plus Lite |
| Dental Monitoring Sas | $420.62 | 2025 | |
| Lightforce Orthodontics, INC. | $156.08 | 2023-2025 | |
| Envista Holdings Corporation | $94.82 | 2024 | Spark, Tf Adaptive |
| Ormco Corporation | $63.04 | 2021-2023 | Spark |
| Dentsply Sirona INC | $41.02 | 2019 | |
| Nobel Biocare USA | $32.53 | 2023 | Nobelactive |
| Colgate Oral Pharmaceuticals, INC. | $28.41 | 2024 | |
| World Class Technology Corporation | $27.63 | 2023 | Pitts21, Pitts21 Pro |
| USA Angelalign Technology Corp | $25.71 | 2023 | |
| 3m Company | $19.73 | 2019 | |
| Gc America INC. | $19.05 | 2019 | |
| Ortho Organizers, INC. | $16.22 | 2019 | |
| Ultradent Products INC | $6.25 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Rozen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.